Search Results - "De Toni, Chiara"

What do cancer patients experience of the simultaneous care clinic? Results of a cross‐sectional study on patient care satisfaction by Galiano, Antonella, Feltrin, Alessandra, Pambuku, Ardi, Lo Mauro, Leda, De Toni, Chiara, Murgioni, Sabina, Soldà, Caterina, Maruzzo, Marco, Bergamo, Francesca, Brunello, Antonella, Zagonel, Vittorina

“…Background Veneto Institute of Oncology has activated a simultaneous care outpatient clinic (SCOC) in which cancer patients with advanced‐stage cancer are…”
Get full text

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma by Procaccio, Letizia, Merz, Valeria, Fasano, Morena, Vaccaro, Vanja, Giommoni, Elisa, Pretta, Andrea, Noventa, Silvia, Satolli, Maria Antonietta, Giordano, Guido, Zichi, Clizia, Pinto, Carmine, Zecchetto, Camilla, Barsotti, Giulia, De Vita, Ferdinando, Milella, Michele, Antonuzzo, Lorenzo, Scartozzi, Mario, Zaniboni, Alberto, Spadi, Rosella, Casalino, Simona, Bergamo, Francesca, De Toni, Chiara, Melisi, Davide, Lonardi, Sara

“…Background The NAPOLI‐I trial showed better outcome of nanoliposomal irinotecan (nal‐IRI) plus 5‐fluorouracil/leucovorin (5‐FU/LV) compared to 5‐FU/LV in…”
Get full text

Psychological assessment and the role of the psychologist in early palliative care by Iannizzi, Pamela, Feltrin, Alessandra, Martino, Rosalba, De Toni, Chiara, Galiano, Antonella, Pambuku, Ardi, Nardi, Mariateresa, Meraviglia, Nicla, Brunello, Antonella, Zagonel, Vittorina

“…BackgroundEarly palliative care (EPC) is a recommended model for improving the quality of life for patients with advanced cancer and their caregivers. However,…”
Get full text

Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study by Buja, Alessandra, Bardin, Andrea, Damiani, Giovanni, Zorzi, Manuel, De Toni, Chiara, Fusinato, Riccardo, Spina, Romina, Vecchiato, Antonella, Del Fiore, Paolo, Mocellin, Simone, Baldo, Vincenzo, Rugge, Massimo, Rossi, Carlo Riccardo

“…Among white people, the incidence of cutaneous malignant melanoma (CMM) has been increasing steadily for several decades. Meanwhile, there has also been a…”
Get full text

Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile by Buja, Alessandra, Rugge, Massimo, De Luca, Giuseppe, Bovo, Emanuela, Zorzi, Manuel, De Toni, Chiara, Cozzolino, Claudia, Vecchiato, Antonella, Del Fiore, Paolo, Spina, Romina, Cinquetti, Sandro, Baldo, Vincenzo, Rossi, Carlo Riccardo, Mocellin, Simone

“…Previous studies associated high-level exposure to ultraviolet radiation with a greater risk of cutaneous malignant melanoma (CMM). This study focuses on the…”
Get full text

Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients by Galiano, Antonella, Schiavon, Stefania, Nardi, Mariateresa, Guglieri, Irene, Pambuku, Ardi, Martino, Rosalba, Bolshinsky, Maital, Murgioni, Sabina, Intini, Rossana, Soldà, Caterina, Marino, Dario, Daniel, Francesca, De Toni, Chiara, Pittarello, Chiara, Chiusole, Benedetta, Prete, Alessandra Anna, Bimbatti, Davide, Nappo, Floriana, Caccese, Mario, Bergamo, Francesca, Brunello, Antonella, Lonardi, Sara, Zagonel, Vittorina

“…BackgroundEarly activation of palliative care for patients with advanced cancer is central in the treatment trajectory. At the Veneto Institute of Oncology, a…”
Get full text

Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial by Bimbatti, Davide, Lai, Eleonora, Pierantoni, Francesco, Maruzzo, Marco, Msaki, Aichi, De Toni, Chiara, Dionese, Michele, Feltrin, Alessandra, Basso, Umberto, Zagonel, Vittorina

“…Testicular cancer (TC) is the most common solid tumor in young adults. 95% of patients are cured, but they may experience late adverse effects (anxiety, fear…”
Get full text

Impact of Wide Local Excision on Melanoma Patient Survival: A Population-Based Study by Buja, Alessandra, Rugge, Massimo, Damiani, Giovanni, De Luca, Giuseppe, Zorzi, Manuel, Fusinato, Riccardo, De Toni, Chiara, Vecchiato, Antonella, Del Fiore, Paolo, Falasco, Francesca, Spina, Romina, Rossi, Carlo Riccardo, Mocellin, Simone

“…Promoting standardization and quality assurance (QA) in oncology on the strength of real-world data is essential to ensure better patient outcomes. Wide…”
Get full text

Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis by Padovan, Marta, Maccari, Marta, Bosio, Alberto, De Toni, Chiara, Vizzaccaro, Salvatore, Cestonaro, Ilaria, Corrà, Martina, Caccese, Mario, Cerretti, Giulia, Zagonel, Vittorina, Lombardi, Giuseppe

“…Next-generation sequencing (NGS) panels enable the identification of alterations in cancer-related genes. This may guide a molecularly targeted strategy for…”
Get full text

Role of geriatric assessment and oncological multidimensional prognostic index (Onco-MPI) in a real-world cohort of elderly patients with advanced urothelial carcinoma by Bimbatti, Davide, Cavasin, Nicolò, Bergo, Eleonora, De Toni, Chiara, Lai, Eleonora, Erbetta, Elisa, Jubran, Salim, Pierantoni, Francesco, Ruffini, Camilla, Brunello, Antonella, Basso, Umberto, Maruzzo, Marco

“…563 Background: At least 75% of bladder cancer (BC) are diagnosed in adults aged ≥65 years, with a median of 72 years. Older adults have poor outcomes but are…”
Get full text

Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs by Buja, Alessandra, Rugge, Massimo, Damiani, Giovanni, Zorzi, Manuel, De Toni, Chiara, Vecchiato, Antonella, Del Fiore, Paolo, Spina, Romina, Baldo, Vincenzo, Brazzale, Alessandra Rosalba, Rossi, Carlo Riccardo, Mocellin, Simone

“…This study aims to provide a comprehensive overview of sex-related characteristics of cutaneous malignant melanoma (CMM), with special reference to its…”
Get more information

Drug-drug interactions (DDIs) in elderly patients with metastatic renal cell carcinoma (mRCC) treated with cabozantinib within the multicenter prospective trial ZEBRA/Meet-URO 9 by Mattana, Alvise, Del Re, Marzia, Bimbatti, Davide, Buti, Sebastiano, Claps, Melanie, Di Napoli, Marilena, Fratino, Lucia, Santini, Daniele, Sorarù, Mariella, Grillone, Francesco, Mazzaschi, Giulia, Maruzzo, Marco, Pierantoni, Francesco, Ballestrin, Melissa, De Toni, Chiara, Lai, Eleonora, Dionese, Michele, Zagonel, Vittorina, Basso, Umberto

“…648 Background: The oral tyrosine kinase inhibitor Cabozantinib (CABO) is frequently used to treat patients with metastatic RCC. Polypharmacy is common in…”
Get full text

HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study by Prete, Alessandra Anna, Angerilli, Valentina, Bergamo, Francesca, Vettore, Valentina, De Toni, Chiara, Intini, Rossana, Cerma, Krisida, Ricagno, Gianmarco, Cerantola, Riccardo, Perissinotto, Eleonora, De Rosa, Antonio, Ceccon, Carlotta, Gasparello, Jessica, Denaro, Luca, D’Amico, Alberto, Chioffi, Franco, Carcea, Elena, Fassan, Matteo, Lonardi, Sara

“…Background Little is known about prognostic factors of brain metastases (BM) from colorectal cancer (CRC). HER2 amplification/overexpression (HER2+) was…”
Get full text

Real-world performance and clinical outcome of comprehensive genomic profiling of gastrointestinal tumors: High-volume, single-center experience by Ricagno, Gianmarco, Angerilli, Valentina, Maddalena, Giulia, De Toni, Chiara, Gasparello, Jessica, Barsotti, Giulia, Mattiuzzo, Elena, Ceccon, Carlotta, Montagna, Aldo, Sabbadin, Marianna, Pittarello, Chiara, Nappo, Floriana, Cerantola, Riccardo, Pante, Francesca, Procaccio, Letizia, Rizzato, Mario Domenico, De Rosa, Antonio, Fassan, Matteo, Bergamo, Francesca, Lonardi, Sara

“…727 Background: In order to identify targetable mutations, the Comprehensive Genomic Profiling (CGP) is an important tool. Technologies like extensive genomic…”
Get full text

Understanding resistance in V600E BRAF advanced colon cancer treated with BRAF inhibitors plus anti-EGFR antibodies +/- MEK inhibitors: The URBAN study by Bergamo, Francesca, Munari, Giada, Cerma, Krisida, Ceccon, Carlotta, Intini, Rossana, Borga, Chiara, Cerantola, Riccardo, Piva, Vittoria Matilde, Angerilli, Valentina, Prete, Alessandra Anna Anna, Montagna, Aldo, Rizzato, Mario Domenico, Sabbadin, Marianna, Barsotti, Giulia, De Toni, Chiara, Procaccio, Letizia, Soldà, Caterina, Dei Tos, Angelo Paolo, Lonardi, Sara, Fassan, Matteo

“…3587 Background: The combination of BRAF inhibitors (BRAFi) plus anti-EGFR antibodies is a new standard of care in V600E BRAF mutated (mut) metastatic…”
Get full text

Cabozantinib in the elderly with metastatic renal cell carcinoma undergoing geriatric G8 screening test: A prospective multicenter observational study (ZEBRA/MEET-URO 9) by Basso, Umberto, Buti, Sebastiano, Verzoni, Elena, Sorarù, Mariella, Di Napoli, Marilena, Fratino, Lucia, Santini, Daniele, Grillone, Francesco, Chiuri, Vincenzo Emanuele Emanuele, Carella, Claudia, Atzori, Francesco, Roviello, Giandomenico, Sartori, Donata, Maruzzo, Marco, Pierantoni, Francesco, Bersanelli, Melissa, Ballestrin, Melissa, De Toni, Chiara, Mattana, Alvise, Zagonel, Vittorina

“…647 Background: Cabozantinib (CABO) is an oral tyrosine kinase inhibitor registered for the treatment of metastatic renal cell carcinoma (mRCC) for the first…”
Get full text

Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience by Bimbatti, Davide, Pierantoni, Francesco, Lai, Eleonora, Ballestrin, Melissa, Cavasin, Nicolò, Erbetta, Elisa, De Toni, Chiara, Basso, Umberto, Maruzzo, Marco

“…Background: Non-clear cell renal cell carcinoma (nccRCC) is a heterogeneous group of cancer. Treatment recommendations are extrapolated from ccRCC and lack…”
Get full text

Immunotherapy in RAS mutant mCRC: Could CTLA-4 blockade increase the efficacy of anti PD-1 agents? Preliminary clinical results of the NERDY study by Prete, Alessandra Anna Anna, Intini, Rossana, Piva, Vittoria Matilde, Angerilli, Valentina, Daniel, Francesca, Barsotti, Giulia, De Grandis, Maria Caterina, Cerma, Krisida, Munari, Giada, Ricagno, Gianmarco, Montagna, Aldo, De Toni, Chiara, Rossi, Silvia, Cerantola, Riccardo, Rasola, Cosimo, Schiavi, Francesca, Fassan, Matteo, Bergamo, Francesca, Zagonel, Vittorina, Lonardi, Sara

“…218 Background: Immune checkpoint inhibitors (ICI) showed high efficacy in both first and subsequent lines in metastatic colorectal cancer with mismatch repair…”
Get full text

Left atrial remodeling in heart failure: the role of sphericity index (the SPHERICAT-HF study) by Sanna, Giuseppe D., Moccia, Eleonora, Canonico, Mario Enrico, Sanna, Silvia, De Toni, Chiara, Santoro, Ciro, Masia, Stefano L., Saderi, Laura, Sotgiu, Giovanni, Parodi, Guido

“…Left atrial sphericity index (LASI) is an echocardiographic index easily obtained; its use in patients with heart failure (HF) has never been investigated so…”
Get full text

SYST-20 TARGETED THERAPY MATCHED TO GENOMIC ALTERATIONS (BRAFV600E, NTRK, FGFR, ROS1, PIK3CA, PTEN) IN PATIENTS WITH RECURRENT IDH WILDTYPE GLIOBLASTOMA: A REAL-LIFE COHORT ANALYSIS FROM VENETO INSTITUTE OF ONCOLOGY, PADUA (ITALY) by Padovan, Marta, De Toni, Chiara, Maccari, Marta, Bosio, Alberto, Cerretti, Giulia, Caccese, Mario, Corrà, Martina, Vizzaccaro, Salvatore, Cestonaro, Ilaria, Pittaro, Alice, Guerriero, Angela, Coppola, Marina, Lombardi, Giuseppe

“…We retrospectively analyzed 34 patients (pts) [19 males, 15 females, median age 54] with recurrent IDH wildtype glioblastoma treated with target therapy (TT)…”
Get full text